These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Management and Outcome of Patients With Acute Coronary Syndrome Caused by Plaque Rupture Versus Plaque Erosion: An Intravascular Optical Coherence Tomography Study. Hu S; Zhu Y; Zhang Y; Dai J; Li L; Dauerman H; Soeda T; Wang Z; Lee H; Wang C; Zhe C; Wang Y; Zheng G; Zhang S; Jia H; Yu B; Jang IK J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28235809 [TBL] [Abstract][Full Text] [Related]
26. Culprit Lesions Phenotypes in ST-Segment Elevation Acute Coronary Syndromes: A Call for Precision Medicine. Capodanno D; Laudani C JACC Cardiovasc Interv; 2022 Apr; 15(8):857-860. PubMed ID: 35367171 [No Abstract] [Full Text] [Related]
27. Myeloperoxidase may help to differentiate coronary plaque erosion from plaque rupture in patients with acute coronary syndromes. Niccoli G; Dato I; Crea F Trends Cardiovasc Med; 2010 Nov; 20(8):276-81. PubMed ID: 22433655 [TBL] [Abstract][Full Text] [Related]
28. Reassessing the Mechanisms of Acute Coronary Syndromes. Libby P; Pasterkamp G; Crea F; Jang IK Circ Res; 2019 Jan; 124(1):150-160. PubMed ID: 30605419 [TBL] [Abstract][Full Text] [Related]
34. Novel risk factors for acute coronary syndromes and emerging therapies. Tong DC; Wilson AM; Layland J Int J Cardiol; 2016 Oct; 220():815-24. PubMed ID: 27394979 [TBL] [Abstract][Full Text] [Related]
35. Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion. Pedicino D; Vinci R; Giglio AF; Pisano E; Porto I; Vergallo R; Russo G; Ruggio A; D'Aiello A; Flego D; Annibali G; Trotta F; Piacentini R; Niccoli G; Liuzzo G; Crea F J Am Coll Cardiol; 2018 Sep; 72(13):1490-1503. PubMed ID: 30236312 [TBL] [Abstract][Full Text] [Related]
36. Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy. Ozaki Y; Okumura M; Ismail TF; Motoyama S; Naruse H; Hattori K; Kawai H; Sarai M; Takagi Y; Ishii J; Anno H; Virmani R; Serruys PW; Narula J Eur Heart J; 2011 Nov; 32(22):2814-23. PubMed ID: 21719455 [TBL] [Abstract][Full Text] [Related]
37. Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions. Centurión OA Cardiovasc Revasc Med; 2016 Mar; 17(2):119-28. PubMed ID: 26905055 [TBL] [Abstract][Full Text] [Related]
38. Updates on Acute Coronary Syndrome: A Review. Eisen A; Giugliano RP; Braunwald E JAMA Cardiol; 2016 Sep; 1(6):718-30. PubMed ID: 27438381 [TBL] [Abstract][Full Text] [Related]
39. Novel oral anticoagulants in acute coronary syndrome. Costopoulos C; Niespialowska-Steuden M; Kukreja N; Gorog DA Int J Cardiol; 2013 Sep; 167(6):2449-55. PubMed ID: 22989603 [TBL] [Abstract][Full Text] [Related]
40. Plaque morphologies and the clinical prognosis of acute coronary syndrome caused by lesions with intact fibrous cap diagnosed by optical coherence tomography. Yonetsu T; Lee T; Murai T; Suzuki M; Matsumura A; Hashimoto Y; Kakuta T Int J Cardiol; 2016 Jan; 203():766-74. PubMed ID: 26590891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]